ArticleLeukemia2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
Alessandro Gozzetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleLeukemia2020
Alessandro Gozzetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.